The COVID-19 vaccination programme provides all those living in Aotearoa New Zealand with the best protection against the worst outcomes of the COVID-19 disease.
The vaccination programme has evolved over the past few years, with three different versions of the mRNA vaccine Comirnaty now used for most people including those aged 12 years and over as a primary course and additional dose.
An adjuvanted recombinant protein vaccine, Nuvaxovid, is also available for those aged 12 years and over as an alternative primary course and can be used as an additional dose for those aged 18 years or over.
From 7 March 2024, everyone in Aotearoa New Zealand over the age of 12 years who is not yet vaccinated can receive a single dose of the monovalent Comirnaty Omicron 30mcg XBB.1.5 grey cap vaccine, whether they are eligible for funded health and disability services or not.
Additional doses are also available to those who are eligible, using this same vaccine. For more information see the IMAC Comirnaty 30mcg XBB.1.5 factsheet. Also see the Manatū Hauora Ministry of Health COVID-19 vaccines webpage and the Immunisation Handbook for more information.
The Comirnaty 10mcg orange cap vaccine is available for children aged 5 to 11 years and is a lower dose and smaller volume than the grey cap vaccines. Two doses are required for best protection.
Comirnaty 3mcg maroon cap vaccine is limited to young children aged between six months and four years of age who are at highest risk of severe infection if they were to catch COVID-19, such as those with severe immunocompromise or with complex and/or multiple health conditions.
Resources can be found on the right-hand side of each specific vaccine page or within our factsheet resources.
View our information and guidance here.
Note: Vaccine labels for Pfizer Adult XBB.1.5 (Gry) 100 packs are not yet available. Stock will be available at HCL and DHL mid-March and can be ordered via the Inventory Portal. The Logistics Team will let providers know when they can commence ordering.
View the recording of our recent XBB.1.5 webinar here. This informative webinar covers a range of issues in relation to the new vaccine.
On behalf of Te Whatu Ora, IMAC provides education and training courses for those administering COVID-19 vaccines or otherwise contributing to the programme. The course selection will depend upon the scope of your role.
Different roles and pathways
View information on the different roles in the immunisation workforce here.
COVID-19 programme-specific courses
View IMAC's COVID-19 courses here.